Adrenocorticotrophic hormone exerts marked lipid-lowering effects in simvastatin-treated patients

Journal of Internal Medicine

Volumn 250, Issue 6, 2001, Pages 530-534

  Hardarson, A ^a   Sigurdsson, G ^a   Olafsdottir, E ^a   Dallongeville, J ^b   Berg, A L ^c   Arnadottir, M ^a  

^a LANDSPITALI UNIVERSITY HOSPITAL   (Iceland)

^b INSTITUT PASTEUR DE LILLE   (France)

^c LUND UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Adrenocorticotrophic hormone; Apolipoproteins; Lipids; Lipoproteins; Simvastatin

Indexed keywords

ANTILIPEMIC AGENT; APOLIPOPROTEIN A1; APOLIPOPROTEIN B; APOLIPOPROTEIN E; CHOLESTEROL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPOPROTEIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; SIMVASTATIN; TETRACOSACTIDE ZINC PHOSPHATE; TRIACYLGLYCEROL;

ADULT; AGED; ARTICLE; BLOOD SAMPLING; CHOLESTEROL BLOOD LEVEL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HUMAN; HYPERCHOLESTEROLEMIA; LIPID ANALYSIS; LIPOPROTEIN BLOOD LEVEL; LONG TERM CARE; MALE; PRIORITY JOURNAL; TRIACYLGLYCEROL BLOOD LEVEL;

ADRENOCORTICOTROPIC HORMONE; AGED; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; HYPERLIPIDEMIAS; MALE; MIDDLE AGED; SIMVASTATIN; STATISTICS, NONPARAMETRIC; TREATMENT OUTCOME;

EID: 0035652615     PISSN: 09546820     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2796.2001.00919.x     Document Type: Article

References (18)

1. Alteration in the expression of genes for cholesterol side-chain cleavage enzyme and 21-hydroxylase by hypophysectomy and ACTH administration in the rat adrenal
2. ACTH1-24 decreases hepatic lipase activities and low density lipoprotein concentrations in healthy men
3. Direct effects of ACTH on plasma lipoprotein metabolism in man - Studies in vivo and in vitro
4. Corticotropin increases the receptor-specific uptake of native low-density lipoprotein (LDL) - But not of oxidized LDL and native or oxidized lipoprotein(a) (Lp(a)) - In HEPG2 cells: No evidence for Lp(a) catabolism via the LDL-receptor
5. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: The Scandinavian Simvastatin Survival Study (4S)
6. Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: Results of AFCAPS/TexCAPS
7. Prevention of coronary heart disease in clinical practice
8. Position statement
9. Changes in plasma high density lipoproteins in chronic male alcoholics during and after abuse
10. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge
11. Apolipoprotein C-III and apo E in apoB- and non-apoB-containing lipoproteins in two populations at contrasting risk for myocardial infarction: The ECTIM study
12. The effect of short-term treatment with corticotropin on the serum apolipoprotein pattern
13. Metabolism of lipoproteins containing apolipoprotein B-100 in blood plasma of rabbits: Heterogeneity related to the presence of apolipoprotein E
14. HMG-CoA reductase inhibitors: A look back and a look ahead
15. Drug therapy. Drug treatment of lipid disorders
16. Effect of simvastatin (40 and 80 mg/day) in patients with mixed hyperlipidemia
17. The efficacy and six-week tolerability of simvastatin 80 and 160 mg/day
18. ACTH revisited - Potential implications for patients with renal disease